Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Better Thinking

#137 – Paul Fitzgerald on Transcranial Magnetic Stimulation Treatment

22 Nov 2023

Description

In this episode of Better Thinking, Nesh Nikolic speaks with Paul Fitzgerald about the development of novel brain stimulation treatment options including repetitive transcranial magnetic stimulation (rTMS) for patients with depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease. Paul Fitzgerald is the Head of the School of Medicine and Psychology at the Australian National University. He is a qualified psychiatrist, has a MBBS degree, Masters of Psychological Medicine and research PhD from Monash University. He has conducted an extensive range of more than 20 clinical trials, especially focussed on the development of novel brain stimulation treatment options including repetitive transcranial magnetic stimulation (rTMS) for patients with depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease. He has had continual NHMRC grant support for over 20 years and over $10 million in research support in the last 5 years. He has published several books, over 500 journal articles and been cited over 20,000 times. He has established multiple clinical rTMS services, founded several device and clinical service companies and the first rTMS training program in Australia. He led a national application to the Department of Health at the Federal Government level and this resulted in Medicare funding $283 million in year 1 of rTMS therapy for patients with depression in 2021. Episode link at https://neshnikolic.com/podcast/paul-fitzgeraldSee omnystudio.com/listener for privacy information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.